Anti-tumor effects of Astragalus on hepatocellular carcinoma in vivo

被引:19
|
作者
Li, Lian-Kun [2 ]
Kuang, Wen-Juan [1 ]
Huang, Yun-Feng [2 ]
Xie, Han-Hong [2 ]
Chen, Guo [2 ]
Zhou, Qing-Chun [2 ]
Wang, Bin-Rong [2 ]
Wan, Li-Hong [1 ]
机构
[1] Sichuan Univ, W China Ctr Med Sci, Dept Pharmacol, Chengdu 610064, Sichuan, Peoples R China
[2] Sichuan Gen Hosp Armed Police Force, Dept Med, Chengdu, Sichuan, Peoples R China
关键词
Antitumor effects; apoptosis; Astragalus; H22; APOPTOSIS; PATHWAY; CELLS;
D O I
10.4103/0253-7613.91872
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: The objective of the present study is to investigate the anti-proliferation activity of Astragalus on human hepatocellular carcinoma (HCC) cells and its mechanism. Materials and Methods: Hepatic cancer H22 bearing mice were used to study the anti-hepatocarcinoma activity of Astragalus in vivo. The growth curve and inhibitory rate of tumor growth were measured. Cell apoptosis of each group was measured by flow cytometry (FCM). Protein expression of Bax and Bcl-2 were analyzed by immunohistochemistry (IHC). The Statistical Package for Social Sciences version 13.0 (SPSS Inc, Chicago, IL) was used for standard statistical analysis including one-way ANOVA and Student's t-test. A value of P<0.05 was considered to be statistically significant. Results: Astragalus significantly inhibited the growth of H22 carcinoma, with an inhibitory rate of 17.28-52.36%. FCM and immunohistochemical assay show that the cell apoptosis rate and protein expression of Bax and Bax/Bcl-2 ratio of H22 transplanted tumor in Astragalus treated group were significantly higher than the control group (P<0.05). The protein expression of Bcl-2 was significantly lower than control (P<0.05). Conclusion: The results of the present study suggest that Astragalus has significant antitumor effect in vivo in inducing apoptosis of H22 tumor cells by promoting protein expression of Bax, decreasing protein expression of Bcl-2 gene, and markedly increasing the Bax/Bcl-2 ratio.
引用
收藏
页码:78 / 81
页数:4
相关论文
共 50 条
  • [1] In vitro and in vivo anti-tumor effects of Astragalus membranaceus
    Cho, William C. S.
    Leung, Kwok N.
    [J]. CANCER LETTERS, 2007, 252 (01) : 43 - 54
  • [2] Anti-Tumor Effects of Carrimycin and Monomeric Isovalerylspiramycin I on Hepatocellular Carcinoma in Vitro and in Vivo
    Jin, Yong
    Zuo, Hong Xiang
    Li, Ming Yue
    Zhang, Zhi Hong
    Xing, Yue
    Wang, Jing Ying
    Ma, Juan
    Li, Gao
    Piao, Hongxin
    Gu, Puqing
    Jin, Xuejun
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [3] Combined anti-tumor effects of IFN-α and sorafenib on hepatocellular carcinoma in vitro and in vivo
    Wang, Lijing
    Jia, Dongwei
    Duan, Fangfang
    Sun, Zhichao
    Liu, Xiaojuan
    Zhou, Lei
    Sun, Linlin
    Ren, Shifang
    Ruan, Yuanyuan
    Gu, Jianxin
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 422 (04) : 687 - 692
  • [4] Enhanced anti-tumor effect of liposomal Fasudil on hepatocellular carcinoma in vitro and in vivo
    Zhao, Ying
    Zhang, Yu
    Mehdiabad, Milad Vazirinejad
    Zhou, Ke
    Chen, Yuyuan
    Li, Lei
    Guo, Jun
    Xu, Chuanrui
    [J]. PLOS ONE, 2019, 14 (10):
  • [5] Synergistic anti-tumor efficacy of doxorubicin and flavopiridol in an in vivo hepatocellular carcinoma model
    Min-Sun Kwak
    Su Jong Yu
    Jung-Hwan Yoon
    Sung-Hee Lee
    Soo-Mi Lee
    Jeong-Hoon Lee
    Yoon Jun Kim
    Hyo-Suk Lee
    Chung Yong Kim
    [J]. Journal of Cancer Research and Clinical Oncology, 2015, 141 : 2037 - 2045
  • [6] Synergistic anti-tumor efficacy of doxorubicin and flavopiridol in an in vivo hepatocellular carcinoma model
    Kwak, Min-Sun
    Yu, Su Jong
    Yoon, Jung-Hwan
    Lee, Sung-Hee
    Lee, Soo-Mi
    Lee, Jeong-Hoon
    Kim, Yoon Jun
    Lee, Hyo-Suk
    Kim, Chung Yong
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (11) : 2037 - 2045
  • [7] Targeting cancer cells and anti-tumor effects of brucine immuno-nanoparticles on hepatocellular carcinoma in vivo
    Qin, Jianmin
    [J]. CANCER RESEARCH, 2012, 72
  • [8] Anti-tumor effects of brucine immuno-nanoparticles on hepatocellular carcinoma
    Qin, Jian-Min
    Yin, Pei-Hao
    Li, Qi
    Sa, Zhong-Qiu
    Sheng, Xia
    Yang, Lin
    Huang, Tao
    Zhang, Min
    Gao, Ke-Pan
    Chen, Qing-Hua
    Ma, Jing-Wei
    Shen, He-Bai
    [J]. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2012, 7 : 369 - 379
  • [9] Anti-tumor activity and mechanism of oligoclonal hepatocellular carcinoma tumor-infiltrating lymphocytes in vivo and in vitro
    Wang, Wen-Chao
    Zhang, Zong-Qin
    Li, Peng-Peng
    Ma, Jun-Yong
    Chen, Lei
    Qian, Hai-Hua
    Shi, Le-Hua
    Yin, Zheng-Feng
    Sun, Bin
    Zhang, Xiao-Feng
    [J]. CANCER BIOLOGY & THERAPY, 2019, 20 (09) : 1187 - 1194
  • [10] Systemic hypoxia potentiates anti-tumor effects of metformin in hepatocellular carcinoma in mice
    Lin, Hui
    Zhou, Wenfang
    Huang, Yonghong
    Ren, Min
    Xu, Fangyun
    Wang, Hongmei
    [J]. ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2020, 52 (04) : 421 - 429